163 related articles for article (PubMed ID: 28108849)
1. Toll Like Receptor 4 Affects the Cerebral Biochemical Changes Induced by MPTP Treatment.
Conte C; Roscini L; Sardella R; Mariucci G; Scorzoni S; Beccari T; Corte L
Neurochem Res; 2017 Feb; 42(2):493-500. PubMed ID: 28108849
[TBL] [Abstract][Full Text] [Related]
2. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
[TBL] [Abstract][Full Text] [Related]
4. TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease.
Zhao XD; Wang FX; Cao WF; Zhang YH; Li Y
Int Immunopharmacol; 2016 Mar; 32():96-102. PubMed ID: 26803521
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease.
Al-Sweidi S; Morissette M; Di Paolo T
J Steroid Biochem Mol Biol; 2016 Jul; 161():84-91. PubMed ID: 26873133
[TBL] [Abstract][Full Text] [Related]
6. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A
Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171
[TBL] [Abstract][Full Text] [Related]
7. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
8. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner.
Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R
Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762
[TBL] [Abstract][Full Text] [Related]
9. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
Luquin MR; Obeso JA; Herrero MT; Laguna J; Martínez-Lage JM
Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
[TBL] [Abstract][Full Text] [Related]
10. Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration.
Kalkonde YV; Morgan WW; Sigala J; Maffi SK; Condello C; Kuziel W; Ahuja SS; Ahuja SK
Brain Res; 2007 Jan; 1128(1):1-11. PubMed ID: 17126305
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
[TBL] [Abstract][Full Text] [Related]
12. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
Ding H; Underwood R; Lavalley N; Yacoubian TA
Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
[TBL] [Abstract][Full Text] [Related]
14. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
[TBL] [Abstract][Full Text] [Related]
15. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease.
Noelker C; Morel L; Lescot T; Osterloh A; Alvarez-Fischer D; Breloer M; Henze C; Depboylu C; Skrzydelski D; Michel PP; Dodel RC; Lu L; Hirsch EC; Hunot S; Hartmann A
Sci Rep; 2013; 3():1393. PubMed ID: 23462811
[TBL] [Abstract][Full Text] [Related]
16. Medicinal plant Combretum leprosum mart ameliorates motor, biochemical and molecular alterations in a Parkinson's disease model induced by MPTP.
Moraes LS; Rohor BZ; Areal LB; Pereira EV; Santos AM; Facundo VA; Santos AR; Pires RG; Martins-Silva C
J Ethnopharmacol; 2016 Jun; 185():68-76. PubMed ID: 26994817
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome activation in the thymus of MPTP-induced Parkinsonian mouse model.
Wen L; Zhang QS; Heng Y; Chen Y; Wang S; Yuan YH; Chen NH
Toxicol Lett; 2018 May; 288():1-8. PubMed ID: 29421335
[TBL] [Abstract][Full Text] [Related]
18. Possible role of GABA-B receptor modulation in MPTP induced Parkinson's disease in rats.
Tyagi RK; Bisht R; Pant J; Kumar P; Majeed AB; Prakash A
Exp Toxicol Pathol; 2015 Feb; 67(2):211-7. PubMed ID: 25547370
[TBL] [Abstract][Full Text] [Related]
19. Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity.
Albi E; Cataldi S; Codini M; Mariucci G; Lazzarini A; Ceccarini MR; Ferri I; Laurenti ME; Arcuri C; Patria F; Beccari T; Conte C
Prostaglandins Other Lipid Mediat; 2019 Jun; 142():46-52. PubMed ID: 30928412
[TBL] [Abstract][Full Text] [Related]
20. Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo ¹H-MRS study of an animal model for Parkinson's disease.
Choi CB; Kim SY; Lee SH; Jahng GH; Kim HY; Choe BY; Ryu KN; Yang DM; Yim SV; Choi WS
Magn Reson Imaging; 2011 Jan; 29(1):32-9. PubMed ID: 20980117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
